tradingkey.logo
tradingkey.logo
Search

Evaxion Biotech A/S

EVAX
Add to Watchlist
2.820USD
+0.030+1.07%
Close 07-31 16:00ETQuotes delayed by 15 min
23.52MMarket Cap
LossP/E TTM

EVAX Financials

See Evaxion Biotech A/S's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Evaxion Biotech A/S Earnings Date

Latest Release
Aug 20, 2026
EPS / Forecast
--/-0.31
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
7.53M
125.12%
EPS(YoY)
-1.20
97.56%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q1
FY2019Q4
Financial Indicators
EPS
69.57%-0.43
95.34%-0.72
108.29%0.73
97.34%-0.77
-122.34%-1.43
96.04%-15.41
98.29%-8.76
94.51%-28.81
101.06%6.40
45.34%-388.85
14.76%-513.20
---525.00
---605.13
---711.43
---602.10
----
----
----
----
----
----
----
----
----
Revenue
--0.00
-100.00%0.00
148.33%7.49M
-75.97%37.00K
-100.00%0.00
67.12%122.00K
--3.02M
--154.00K
--51.00K
--73.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
-129.68%-3.63M
-63.08%-5.92M
338.66%4.62M
22.06%-4.83M
-232.33%-1.58M
19.77%-3.63M
65.92%-1.94M
-9.06%-6.20M
119.13%1.19M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
----
----
----
----
Net Margin
----
96.56%-102.38%
196.11%61.64%
-224.42%-13056.76%
----
51.99%-2974.59%
---64.14%
---4024.68%
--2341.18%
---6195.89%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
-67.35%26.42%
----
-27.02%50.26%
----
-4.07%80.91%
----
9.97%68.87%
----
81.13%84.34%
----
--62.62%
----
--46.56%
----
----
----
----
----
----
----
----
----
----
Revenue
--0.00
-100.00%0.00
148.33%7.49M
-75.97%37.00K
-100.00%0.00
67.12%122.00K
--3.02M
--154.00K
--51.00K
--73.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
1.27%-3.82M
-0.70%-4.05M
274.58%3.02M
5.26%-4.34M
12.01%-3.87M
7.79%-4.02M
69.96%-1.73M
19.31%-4.58M
31.25%-4.40M
33.12%-4.36M
5.28%-5.76M
9.30%-5.68M
0.08%-6.39M
15.49%-6.53M
-2.89%-6.08M
10.92%-6.26M
-23.65%-6.40M
-66.22%-7.72M
---5.91M
---7.03M
----
----
----
----
Net Profit
-129.68%-3.63M
-63.08%-5.92M
338.66%4.62M
22.06%-4.83M
-232.33%-1.58M
19.77%-3.63M
65.92%-1.94M
-9.06%-6.20M
119.13%1.19M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
----
----
----
----
Current assets
----
184.10%24.90M
----
69.88%18.18M
----
4.97%8.77M
----
-5.87%10.70M
----
-50.84%8.35M
----
-60.16%11.37M
----
-51.06%16.98M
----
21.79%28.53M
8.91%35.38M
216.94%34.70M
56.70%16.32M
--23.43M
----
----
----
----
Total current liabilities
----
-2.54%4.26M
----
39.28%5.32M
----
-38.34%4.37M
----
-5.65%3.82M
----
88.30%7.08M
----
-8.12%4.05M
----
-12.98%3.76M
----
-8.19%4.41M
-22.09%4.69M
-12.26%4.32M
16.31%3.92M
--4.80M
----
----
----
----
Total assets
-6.33%23.64M
127.54%28.41M
95.83%29.74M
47.39%22.45M
11.41%25.24M
-3.13%12.48M
27.16%15.19M
-9.09%15.23M
10.57%22.65M
-41.48%12.89M
-56.49%11.94M
-50.73%16.75M
-50.13%20.49M
-45.16%22.02M
13.81%27.45M
22.95%34.00M
17.65%41.08M
235.67%40.16M
113.89%24.12M
--27.66M
----
----
----
----
Total liabilities
-29.95%10.44M
-19.58%11.37M
-13.06%13.14M
16.06%16.22M
-25.71%14.90M
-19.76%14.14M
2.96%15.11M
-1.69%13.98M
44.11%20.05M
28.39%17.62M
5.60%14.68M
2.63%14.22M
-5.32%13.91M
77.61%13.72M
86.15%13.90M
137.71%13.85M
106.35%14.69M
56.81%7.73M
121.41%7.47M
--5.83M
----
----
----
----
Total equity
27.69%13.21M
1131.42%17.04M
-22531.08%-16.60M
396.89%6.23M
297.20%10.34M
65.07%-1.65M
102.71%74.00K
-50.57%1.25M
-60.40%2.60M
-156.96%-4.73M
-120.18%-2.73M
-87.42%2.54M
-75.08%6.58M
-74.40%8.30M
-18.63%13.55M
-7.69%20.15M
-5.07%26.39M
360.88%32.44M
110.68%16.65M
--21.83M
----
----
----
----
Net operating income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
30.69%-5.19M
-102.87%-8.19M
6.33%-4.12M
---6.29M
---7.49M
-36.78%-4.04M
-98.42%-4.39M
---2.95M
---2.21M
Net investment
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
84.44%-77.00K
51.38%-159.00K
37.01%-177.00K
---331.00K
---495.00K
-303.70%-327.00K
-497.87%-281.00K
---81.00K
---47.00K
Net financing
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-757.14%-300.00K
-69.36%7.74M
938.46%24.65M
---65.00K
---35.00K
140388.89%25.25M
872.95%2.37M
---18.00K
--244.00K

FAQs

What is the total revenue of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its total revenue reached 7.53M, with a year-on-year change of 3.34M.

What are the current assets of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its current assets were 24.90M, with a year-on-year change of 184.10.

What are the total assets of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its total assets of Evaxion Biotech A/S were 28.41M, with a year-on-year change of 127.54.

What are the total liabilities of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its total liabilities of Evaxion Biotech A/S were 11.37M, with a year-on-year change of -19.58.

What is the total equity of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its total equity of Evaxion Biotech A/S was 17.04M, with a year-on-year change of 1131.42.

What is the net operating income of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its net operating income of Evaxion Biotech A/S was -9.23M, with a year-on-year change of 37.32.

What is the net investment of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its net investment of Evaxion Biotech A/S was -14.00K, with a year-on-year change of -366.67.

What is the net financing of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its net financing of Evaxion Biotech A/S was 22.41M, with a year-on-year change of 70.69.

What is the Earnings Per Share (EPS) of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its Earnings Per Share (EPS) was -1.20, with a year-on-year change of 97.56.

What is the net income of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its net income was -7.71M, with a year-on-year change of 27.07.

What is the net margin of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its net profit margin was -102.38, with a year-on-year change of 67.60.

What is the debt-to-asset ratio of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its debt-to-asset ratio was 26.42, with a year-on-year change of -67.35.

What is the Return on Assets (ROA) of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its Return on Assets (ROA) was -37.69, with a year-on-year change of 54.74.

What is the operating profit of Evaxion Biotech A/S?

According to Evaxion Biotech A/S's FY2025 earnings report, its operating profit was -9.23M, with a year-on-year change of 37.32.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.